Vaccine
                One-shot chikungunya vaccine found safe, effective in first phase 3 trial: Lancet study
            
                Mask mandates for children may do more harm than good: public health expert
            
                Serum Institute of India restarts manufacturing of COVID-19 vaccine Covishield
            
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg)
/newsdrum-in/media/media_files/WasyZFS0k0uccxJQoJdz.jpg)
/newsdrum-in/media/media_files/eBoYnnR6SorfsVaAJV5B.jpg)
/newsdrum-in/media/media_files/CrnKXAVd66xOhrStwv4h.jpg)
/newsdrum-in/media/media_files/ovUbzfZOY8ZazCjOsXZh.jpg)
/newsdrum-in/media/media_files/E0GZ6lPvwVebGXPcU31P.jpg)
/newsdrum-in/media/media_files/nDQQkZYazus7rgaW8T1X.webp)
/newsdrum-in/media/media_files/tnk3D5oYv17Lej3L7M2N.webp)
/newsdrum-in/media/media_files/I6pHwifu4KumhDQGAmF4.jpg)
/newsdrum-in/media/media_files/gjWQHQes5McDyaNvxOrb.jpg)
